4.6 Article

Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinoma

Related references

Note: Only part of the references are listed.
Article Oncology

Genetic Variant of CXCR1 (rs2234671) Associates with Clinical Outcome in Perihilar Cholangiocarcinoma

Isabella Lurje et al.

Summary: The genetic variant of CXCR1 +860C>G may serve as a molecular marker for DFS, CSS, and OS in patients undergoing curative-intent surgery for pCCA.

LIVER CANCER (2022)

Review Oncology

Prognostic and Predictive Molecular Markers in Cholangiocarcinoma

Sandra Pavicevic et al.

Summary: Cholangiocarcinoma is a rapidly increasing global malignancy of the biliary tract, often presenting with advanced or unresectable disease. Biomarkers obtained from patients' serum or tumor tissue could help guide therapy and identify those at higher risk of recurrence. Genetic aberrations in cholangiocarcinoma have also been linked with improved response to targeted therapies. This review provides an overview of prognostic and predictive biomarkers in cholangiocarcinoma.

CANCERS (2022)

Article Geriatrics & Gerontology

Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma

Jinhuan Yang et al.

Summary: This study found that sarcopenia is associated with adverse outcomes after liver resection for HCC, with higher rates of major complications, blood transfusion, hospitalization expenses, and longer hospital stay. Evaluating sarcopenia upon admission can help classify high-risk patients and reduce the risk of major complications.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Article Gastroenterology & Hepatology

The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma

Isabella Lurje et al.

Summary: This study investigated the prevalence of body composition (BC) alterations and their prognostic role for surgical patients with cholangiocarcinoma (CCA). The study found that sarcopenic obesity may affect long-term survival, indicating that imaging-based analysis of BC could aid preoperative patient selection.

HEPATOLOGY COMMUNICATIONS (2022)

Article Gastroenterology & Hepatology

Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosis

Cornelius Engelmann et al.

Summary: The distribution of body fat plays a significant role in the complications and outcome of liver cirrhosis both before and after transplantation. A decrease in subcutaneous fat index is associated with increased ascites and C-reactive protein levels, as well as an increased risk of cirrhosis-related complications and death on the transplant wait list. Increased paraspinal and visceral fat are correlated with elevated creatinine levels and predictive of one-year mortality after transplantation.

HEPATOLOGY COMMUNICATIONS (2022)

Article Gastroenterology & Hepatology

Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites

Xiang Zhang et al.

Summary: High dietary cholesterol leads to sequential progression of steatosis, steatohepatitis, fibrosis and eventually HCC in mice, concomitant with insulin resistance. Cholesterol-induced NAFLD-HCC formation is associated with gut microbiota dysbiosis, with specific bacterial composition changes between stages of liver disease. Alterations in gut bacterial metabolites were also observed with dietary cholesterol intake. Therapies targeting cholesterol and gut microbiota may be effective for preventing NAFLD-HCC.
Review Gastroenterology & Hepatology

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

Daniel Q. Huang et al.

Summary: The prevalence of NAFLD-related HCC is projected to continue rising globally, with NASH expected to increase and obesity as a major risk factor. Urgent measures are needed to address this growing problem.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Multidisciplinary Sciences

Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status

Kyohei Yugawa et al.

Summary: This study investigated the relationship between BMI and the long-term outcomes of patients with intrahepatic cholangiocarcinoma (ICC). The results showed that patients in the obesity group had significantly worse prognoses, and BMI displayed a positive correlation with F-18-FDG uptake. Obesity was associated with larger tumor size and higher intrahepatic metastasis rate in ICC patients.

SCIENTIFIC REPORTS (2021)

Article Geriatrics & Gerontology

The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation

Zoltan Czigany et al.

Summary: Myosteatosis is an important prognostic marker in patients undergoing deceased donor liver transplantation, particularly in the early post-operative phase. Low skeletal muscle mass alone is not significantly associated with graft and patient survival. Preoperative myosteatosis may be crucial for predicting outcomes in OLT recipients.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)

Article Multidisciplinary Sciences

Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH

Michael Dudek et al.

Summary: Liver resident CD8 T cells play an essential role in immunopathology in a mouse model of nonalcoholic steatohepatitis. These cells display specific phenotypic and metabolic characteristics in the liver, making them susceptible to metabolic stimuli and leading to auto-aggressive responses. This study sheds light on the mechanisms underlying liver damage in NASH and highlights the distinction between auto-aggressive and protective T cell immunity.

NATURE (2021)

Article Gastroenterology & Hepatology

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

Donghee Kim et al.

Summary: This study demonstrated that metabolic dysfunction-associated fatty liver disease (MAFLD) was associated with an increased risk of all-cause mortality in US adults, while non-alcoholic fatty liver disease (NAFLD) showed no association with all-cause mortality after adjusting for metabolic risk factors. Individuals who met the criteria for MAFLD but not NAFLD had a higher risk of all-cause mortality.

JOURNAL OF HEPATOLOGY (2021)

Article Medicine, General & Internal

Association of Body Composition and Sarcopenia with NASH in Obese Patients

Sophia Marie-Therese Schmitz et al.

Summary: In obese patients, higher body fat mass is associated with NASH, rather than sarcopenia. The study found that patients with NASH had significantly higher fat mass, while SMM and SMI associated with NASH also increased significantly.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment

Markus S. Jordens et al.

Summary: This study assessed the prognostic significance of sarcopenia and myosteatosis using routine abdominal CT scans in advanced stage CCA patients undergoing palliative treatment. The results showed that L3SMI, L3PMI, and MMA are negative prognostic factors associated with reduced overall survival in these patients.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Gastroenterology & Hepatology

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis

Oliver Clements et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Jesus M. Banales et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Biochemistry & Molecular Biology

Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer

Isabella Lurje et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Gastroenterology & Hepatology

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Zobair Younossi et al.

HEPATOLOGY (2019)

Review Oncology

Sarcopenia in pancreatic cancer - effects on surgical outcomes and chemotherapy

Miu Yee Chan et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)

Article Geriatrics & Gerontology

Sarcopenia: A Time for Action. An SCWD Position Paper

Juergen Bauer et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib

Atsushi Hiraoka et al.

HEPATOLOGY RESEARCH (2017)

Review Nutrition & Dietetics

ESPEN expert group recommendations for action against cancer-related malnutrition

J. Arends et al.

CLINICAL NUTRITION (2017)

Article Oncology

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

Yizhou Wang et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

3D Slicer as an image computing platform for the Quantitative Imaging Network

Andriy Fedorov et al.

MAGNETIC RESONANCE IMAGING (2012)

Article Gastroenterology & Hepatology

Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical Treatment

Ya-yong Li et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2011)